DNA fingerprinting ofNeisseria meningitidis B. E. KristiansenB. SørensenK. Bøvre BriefCommunication Pages: 200 - 201
Evidence for clonal structure inNeisseria meningitidis: Relevance to epidemiology T. OlyhoekB. CroweM. Achtman OriginalPaper Pages: 202 - 205
Emergence of group B type 15 strains as a cause of meningococcal infection in England and Wales D. M. JonesJ. EldridgeE. M. Sutcliffe BriefCommunication Pages: 206 - 207
Neisseria meningitidis type 15/subtype Pl. 16 in the Netherlands P. BolL. SpanjaardH. C. Zanen BriefCommunication Pages: 212 - 213
Neisseria meningitidis type 15/subtype Pl. 16 in the Netherlands P. BolL. SpanjaardH. C. Zanen BriefCommunication Pages: 214 - 215
Recurrent localized outbreaks of group C meningococcal disease and selective vaccination programmes T. RønneI. LindH. Zoffmann BriefCommunication Pages: 221 - 222
Meningococcal disease in the Faeroe Islands I. LindH. D. JoensenH. Zoffmann BriefCommunication Pages: 223 - 224
Safety and antigenicity studies of a polyvalent meningococcal protein-polysaccharide vaccine W. D. ZollingerJ. W. BoslegoJ. Ray OriginalPaper Pages: 225 - 228
Human immune response to an aluminum hydroxide absorbedNeisseria meningitidis serotype 2b protein vaccine Carl E. FraschJohn M. Zahradnik BriefCommunication Pages: 229 - 231
Characteristics of an alternative meningococcal type 15 (Pl. 16) outer membrane protein vaccine E. C. BeuveryM. WitvlietL. H. J. C. Danse OriginalPaper Pages: 232 - 235
Semi-synthetic carbohydrate antigens as vaccines against group B meningococci Harold J. Jennings BriefCommunication Pages: 236 - 238
Preliminary results from a clinical trail with a meningococcal vaccine containing serotype 2b and 15 antigens in complex with mixed A, C, Y and W135 polysaccharides L. O. FrøholmB. P. BerdalW. D. Zollinger BriefCommunication Pages: 239 - 241
Sero- and subtyping of non-2a, non-2b, and non-15 group BNeisseria meningitidis H. AbdillahiJ. T. PoolmanH. C. Zanen BriefCommunication Pages: 242 - 244
Meningococcal serotypes in Canada, 1977–1984 F. E. AshtonJ. A. RyanB. B. Diena BriefCommunication Pages: 245 - 246
The relationship between endotoxin liberation and serotypes of 25 serogroup B meningococcal strains isolated from patients and carriers B. M. AndersenO. SolbergL. O. Frøholm BriefCommunication Pages: 247 - 248
Enzyme polymorphism inNeisseria meningitidis isolates from Norway D. A. GaugantK. BøvreL. O. Frøholm BriefCommunication Pages: 249 - 250
Serotypes of group BNeisseria meningitidis isolated from meningococcal disease in Scotland R. J. FallonW. M. Brown BriefCommunication Pages: 251 - 252
Diagnostic use of monoclonal IgG antibody to meningococcal B polysaccharide in cerebrospinal fluid M. FroschW. PeuckertD. Bitter-Suermann BriefCommunication Pages: 253 - 254
Phenoxymethyl-penicillin treatment of household contacts of meningococcal disease patients E. A. HøibyP. J. MoeK. Bøvre BriefCommunication Pages: 255 - 257
Meningococcal disease in Iceland, 1975–1984 Kristin E. Jónsdóttir BriefCommunication Pages: 258 - 258
Human opsonins to meningococci after vaccination with a serogroup ACYW135 polysaccharide-serotype 2b, 15 protein vaccine A. HalstensenL. O. FrøholmW. D. Zollinger BriefCommunication Pages: 259 - 259
Development ofNeisseria meningitidis serotype 15 protein/polysaccharide vaccine and evaluation in a mouse model E. RosenqvistC. E. Frasch BriefCommunication Pages: 260 - 262
Do antibodies to meningococcal group B polysaccharide bind to the brain tissue of infant rats? K. SaukkonenM. Leinonen BriefCommunication Pages: 263 - 264
Human antibody response to a group B serotype 2a meningococcal vaccine studied by an immunoblotting technique E. WedegeL. O. Frøholm BriefCommunication Pages: 265 - 266
Analysis of meningococcal lipopolysaccharide and core oligosaccharide by HPLC gel permeation and ELISA inhibition technique P. A. van de WielT. A. BoxE. C. Beuvery BriefCommunication Pages: 267 - 269
Escherichia coli K51 and K93 capsular polysaccharides are cross-reactive with the Group A capsular polysaccharide ofNeisseria meningitidis: immunochemical, structural and epidemiological studies N. GuirguisR. SchneersonA. Elkholy BriefCommunication Pages: 270 - 271
